57276-32-1 Usage
Explanation
Different sources of media describe the Explanation of 57276-32-1 differently. You can refer to the following data:
1. This is the formal name of the compound, which describes its structure and components.
2. The molecular formula represents the count of atoms of each element in the compound, which is 9 carbon (C), 9 hydrogen (H), 1 nitrogen (N), and 1 oxygen (O) atom.
3. The compound is in a liquid state and appears colorless, which means it does not have any visible color.
4. The compound does not dissolve completely in water, indicating that it has limited solubility in aqueous solutions.
5. The compound has a noticeable and pleasant aroma that can be described as a combination of sweet and fruity scents.
6. The compound is used as an intermediate in the production of different drugs, making it an important component in the pharmaceutical sector.
7. Research has been conducted on the compound's ability to control pests and insects, which could lead to its use in insecticides and pesticides.
8. The compound should be handled with care, as it can easily catch fire and may cause discomfort or damage to the skin, eyes, and respiratory system upon exposure.
Physical State
Colorless liquid
Solubility
Slightly soluble in water
Odor
Strong, sweet, and fruity
Applications
Building block in pharmaceutical industry, synthesis of various drugs
Potential Uses
Insecticidal and pesticidal properties
Safety Precautions
Flammable, causes skin, eye, and respiratory irritation
Check Digit Verification of cas no
The CAS Registry Mumber 57276-32-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,2,7 and 6 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 57276-32:
(7*5)+(6*7)+(5*2)+(4*7)+(3*6)+(2*3)+(1*2)=141
141 % 10 = 1
So 57276-32-1 is a valid CAS Registry Number.
57276-32-1Relevant articles and documents
Small molecule that reverses dexamethasone resistance in t-cell acute lymphoblastic leukemia (T-ALL)
Cantley, Alexandra M.,Welsch, Matthew,Ambesi-Impiombato, Alberto,Sanchez-Martin, Marta,Kim, Mi-Yeon,Bauer, Andras,Ferrando, Adolfo,Stockwell, Brent R.
supporting information, p. 754 - 759 (2014/08/05)
Glucocorticoids are one of the most utilized and effective therapies in treating T-cell acute lymphoblastic leukemia. However, patients often develop resistance to glucocorticoids, rendering these therapies ineffective. We screened 9517 compounds, selected for their lead-like properties, chosen from among 3372615 compounds, against a dexamethasone-resistant T-ALL cell line to identify small molecules that reverse glucocorticoid resistance. We synthesized analogues of the most effective compound, termed J9, from the screen in order to define the scaffolds structure-activity relationship. Active compounds restored sensitivity to glucocorticoids through upregulation of the glucocorticoid receptor. This compound and mechanism may provide a strategy for overcoming glucocorticoid resistance in patients with T-ALL.
